AHCCCS; antipsychotic drugs; authorization

This bill (SB 1672) modifies Arizona's Medicaid program (AHCCCS) to change how coverage is provided for prescription antipsychotic drugs. It directly affects AHCCCS members aged 18+ with a serious mental illness diagnosis who need FDA-approved antipsychotic medications. The key provision prevents prior authorization delays for these drugs, except when a step therapy protocol requires documented failure to respond to two distinct antipsychotics. This protocol must be processed electronically in real-time and considers two paid claims for different preferred antipsychotics as meeting the step therapy requirement. The bill applies only to evidence-based antipsychotic drugs and does not affect generic drug use or necessary safety reviews.